Literature DB >> 25031901

Assessment of red blood cell parameters and peripheral smear at different temperatures in case of cold agglutination disease.

V Gupta1.   

Abstract

Cold agglutination disease (CAD) is characterized by an auto-antibody which is able to agglutinate red blood cells (RBCs) at temperatures lower than that of the body, and subsequently to activate the complement system responsible for lysis of RBCs. Patients show hemolytic anemia of varying degrees of severity, which arise or worsen upon exposure to low temperatures. We describe a case who presented with fever and symptoms of asthenia. His investigations yielded bizarre RBC parameters which led to suspicion of a rare CAD, which was confirmed on reviewing RBC parameters, peripheral smear and direct Coomb's test at different temperatures. Hence, we suggest assessment of bizarre RBC parameters and peripheral smear can help in laboratory testing and diagnosis of CAD. It should also not pose embarrassment in laboratory testing to the pathologist for making an early and accurate diagnosis, thus emphasizing the need for an early treatment of CAD.

Entities:  

Keywords:  Cold agglutination disease; Peripheral smear; Red blood cell parameters

Year:  2014        PMID: 25031901      PMCID: PMC4083734          DOI: 10.4103/2141-9248.131703

Source DB:  PubMed          Journal:  Ann Med Health Sci Res        ISSN: 2141-9248


  4 in total

Review 1.  The cold hemagglutinin disease.

Authors:  H Schubothe
Journal:  Semin Hematol       Date:  1966-01       Impact factor: 3.851

2.  Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre.

Authors:  R J Sokol; S Hewitt; B K Stamps
Journal:  Br Med J (Clin Res Ed)       Date:  1981-06-20

3.  Clinical patterns and hematological spectrum in autoimmune hemolytic anemia.

Authors:  Vanamala Alwar; Devi A M Shanthala; S Sitalakshmi; R K Karuna
Journal:  J Lab Physicians       Date:  2010-01

Review 4.  Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy.

Authors:  Sigbjørn Berentsen; Klaus Beiske; Geir E Tjønnfjord
Journal:  Hematology       Date:  2007-10       Impact factor: 2.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.